Barbara Duncan
2013
In 2013, Barbara Duncan earned a total compensation of $1.4M as Chief Financial Officer and Treasurer at Intercept Pharmaceuticals, a 17% increase compared to previous year.
Compensation breakdown
| Bonus | $225,875 |
|---|---|
| Option Awards | $717,750 |
| Salary | $331,000 |
| Stock Awards | $95,700 |
| Other | $8,013 |
| Total | $1,378,338 |
Duncan received $717.8K in option awards, accounting for 52% of the total pay in 2013.
Duncan also received $225.9K in bonus, $331K in salary, $95.7K in stock awards and $8K in other compensation.
Rankings
In 2013, Barbara Duncan's compensation ranked 5,281st out of 12,286 executives tracked by ExecPay. In other words, Duncan earned more than 57.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,281 out of 12,286 | 57th |
Division Manufacturing | 1,824 out of 4,612 | 61st |
Major group Chemicals And Allied Products | 524 out of 1,466 | 64th |
Industry group Drugs | 374 out of 1,160 | 68th |
Industry Pharmaceutical Preparations | 298 out of 890 | 67th |
Source: SEC filing on June 20, 2016.
Duncan's colleagues
We found three more compensation records of executives who worked with Barbara Duncan at Intercept Pharmaceuticals in 2013.